H19 and triple-negative breast carcinoma: Previous evidence had identified BET family proteins as regulators of integrin signaling in triple-negative breast cancer and non-small cell lung cancer [54,55], but the contribution of non-coding RNAs such as H19 to this regulatory axis was not explored.